Abstract:BACKGROUND:Non-alcoholic fatty liver disease has become the most common chronic liver disease worldwide, which originates from the accumulation of triglyceride (TG) in the liver. Patients with type 2 diabetes mellitus (T2DM) are considered to have a predisposition to hepatic steatosis. However, the influencing factors for hepatic fat accumulation in T2DM patients remain unclear.AIM:To investigate the influencing factors for hepatic fat accumulation in T2DM patients.METHODS:We enrolled 329 T2DM patients admitted to the Endocrinology Department of the First Affiliated Hospital of Soochow University, who underwent MR mDIXON-Quant examination to quantify the hepatic fat fraction (HFF). According to body mass index (BMI), the patients were divided into normal weight, overweight, and obese groups. The differences in general statistics, biochemical parameters, islet function, and HFF were compared among the three groups. The associations between HFF and other parameters and the influences of various parameters on the severity of hepatic fat accumulation were analyzed.RESULTS:The HFF of T2DM patients gradually increased in the normal weight, overweight, and obese groups (P < 0.05). Spearman correlation analysis showed that in T2DM patients, HFF was negatively correlated with age and high-density lipoprotein cholesterol (P < 0.05), whereas it was positively correlated with BMI, waist-hip ratio, fasting plasma glucose, alanine aminotransferase (ALT), aspartate aminotransferase, bilirubin, glutamyl transpeptidase, lactate dehydrogenase, albumin (ALB), uric acid (UA), total cholesterol, TG, low-density lipoprotein cholesterol (LDL-C), C-reactive protein, free triiodothyronine, fasting insulin, fasting C-peptide, and homeostasis model assessment of insulin resistance (P < 0.05). Multiple linear regression analysis showed significant positive influences of BMI, ALT, LDL-C, UA, and ALB on HFF in T2DM patients (P < 0.05). Binary logistic regression analysis showed that BMI, ALT, ALB, and LDL-C were independent risk factors for moderate to severe fatty liver in T2DM patients, and obesity increased the risk of being complicated with moderate to severe fatty liver by 4.03 times (P < 0.05).CONCLUSION:The HFF of T2DM patients increases with BMI. Higher BMI, ALT, ALB, and LDL-C are independent risk factors for moderate to severe fatty liver in T2DM patients.

The Role of Hepatic Fat Accumulation in Glucose and Insulin Homeostasis—Dysregulation by the Liver

Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones

Hepatocytes: critical for glucose homeostasis

The Role of Hepatic Fat Accumulation in Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD)

Liver fat accumulation is associated with increased insulin secretion independent of total, visceral, and pancreatic fat

Metabolic Crosstalk: Molecular Links Between Glycogen and Lipid Metabolism in Obesity

Insulin Hypersecretion as Promoter of Body Fat Gain and Hyperglycemia

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease

Influencing Factors for Hepatic Fat Accumulation in Patients with Type 2 Diabetes Mellitus

Adipose Triglyceride Lipase in Hepatic Physiology and Pathophysiology

Targeting fatty acid metabolism to improve glucose metabolism

Hepatic Acetyl CoA Links Adipose Tissue Inflammation to Hepatic Insulin Resistance and Type 2 Diabetes.

Causes and metabolic consequences of Fatty liver.

Insulin signaling to hepatic lipid metabolism in health and disease

Hepatic Insulin Resistance is Not Pathway Selective in Humans with Nonalcoholic Fatty Liver Disease

The Role of Acyl-CoA Synthetase 1 in Bioactive Lipid Accumulation and the Development of Hepatic Insulin Resistance

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease

The metabolic triad of non‐alcoholic fatty liver disease, visceral adiposity and type 2 diabetes: Implications for treatment

Role of fatty acids in the pathogenesis of ß-cell failure and Type-2 diabetes

Hyperglucagonaemia and amino acid alterations in individuals with type 2 diabetes and non-alcoholic fatty liver disease

Role of liver parameters in diabetes mellitus – a narrative review